Qing Song Health Co.,Ltd. (TPE:6931)
38.80
-0.80 (-2.02%)
At close: Jul 17, 2026
Qing Song Health Revenue
Qing Song Health had revenue of 304.63M TWD in the quarter ending March 31, 2026, with 18.05% growth. This brings the company's revenue in the last twelve months to 1.17B, up 15.21% year-over-year. In the year 2025, Qing Song Health had annual revenue of 1.12B with 14.16% growth.
Revenue (ttm)
1.17B
Revenue Growth
+15.21%
P/S Ratio
2.20
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.57B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.12B | 139.14M | 14.16% |
| Dec 31, 2024 | 982.56M | 113.90M | 13.11% |
| Dec 31, 2023 | 868.66M | 231.98M | 36.43% |
| Dec 31, 2022 | 636.69M | 279.15M | 78.08% |
| Dec 31, 2021 | 357.54M | 117.30M | 48.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 17.50B |
| ShareHope Medicine | 4.38B |
| Wellell | 2.43B |
| Chunghwa Chemical Synthesis & Biotech | 973.15M |
| A Plus Biotechnology | 858.89M |
| MARX Biotech | 635.85M |
| Caliway Biopharmaceuticals | 38.04M |
| GlycoNex Incorporation | 36.35M |